Armata Pharmaceuticals Inc. is a clinical-stage biotechnology company based in Marina del Rey, California, focused on developing bacteriophage-based therapies to address the pressing issue of antibiotic-resistant infections. The company employs advanced technologies and robust research capabilities to create targeted treatment solutions that play a critical role in managing infectious diseases. With a promising pipeline of innovative therapeutic candidates and strategic collaborations, Armata is poised to lead the charge against antimicrobial resistance and enhance patient outcomes, ultimately aiming to set new benchmarks for care in the global healthcare arena.

NYSE MKT

USA

HEALTHCARE

BIOTECHNOLOGY

5005 MCCONNELL AVENUE, LOS ANGELES, CA, UNITED STATES, 90066

December

$287 Million

-$31.9 Million

0.0

-1.66

$0.00

0.0%

1.306